SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Sold by GFS Advisors LLC

GFS Advisors LLC trimmed its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 6.6% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 17,706 shares of the exchange traded fund’s stock after selling 1,251 shares during the quarter. GFS Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $1,595,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also made changes to their positions in XBI. Healthcare of Ontario Pension Plan Trust Fund lifted its position in SPDR S&P Biotech ETF by 198.6% during the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 9,229,000 shares of the exchange traded fund’s stock worth $911,825,000 after buying an additional 6,138,000 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd acquired a new stake in shares of SPDR S&P Biotech ETF in the 3rd quarter worth $141,284,000. Mirae Asset Securities USA Inc. raised its holdings in shares of SPDR S&P Biotech ETF by 50.0% during the 3rd quarter. Mirae Asset Securities USA Inc. now owns 900,000 shares of the exchange traded fund’s stock worth $88,920,000 after acquiring an additional 300,000 shares during the period. Assetmark Inc. boosted its position in shares of SPDR S&P Biotech ETF by 72,653.0% during the 3rd quarter. Assetmark Inc. now owns 589,299 shares of the exchange traded fund’s stock valued at $58,223,000 after acquiring an additional 588,489 shares during the last quarter. Finally, Whittier Trust Co. grew its holdings in shares of SPDR S&P Biotech ETF by 3.3% in the third quarter. Whittier Trust Co. now owns 311,027 shares of the exchange traded fund’s stock valued at $30,729,000 after purchasing an additional 9,976 shares during the period.

SPDR S&P Biotech ETF Trading Down 0.9 %

SPDR S&P Biotech ETF stock opened at $92.67 on Friday. The company has a 50-day moving average price of $93.24 and a 200 day moving average price of $96.72. SPDR S&P Biotech ETF has a 12-month low of $81.14 and a 12-month high of $105.47. The stock has a market cap of $7.06 billion, a P/E ratio of 11.47 and a beta of 1.11.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.